Child with Hemophilia A presenting claw hand deformity treated with Emicizumabe: excellent clinical result associated to lower financial cost
Objective: Exemplify how prophylaxis using Emicizumabe (EMZ) in children with Hemophilia A can be more effective and less costly than standard management. Patients presenting antibodies against Factor VIII are treated with prophylactic intravenous bypassing medicines, e.g., recombinant Factor VIIa (...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Boek |
| Gepubliceerd in: |
Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia,
2022-12-01T00:00:00Z.
|
| Onderwerpen: | |
| Online toegang: | Connect to this object online. |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
Connect to this object online.3rd Floor Main Library
| Plaatsingsnummer: |
A1234.567 |
|---|---|
| Kopie 1 | Beschikbaar |